Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice

Neuroscience Letters

Volumn 614, Issue , 2016, Pages 77-82

  Shen, Ji Duo ^a   Ma, Li Gang ^a   Hu, Chun Yue ^a   Pei, Yang Yi ^a   Jin, Shuang Li ^a   Fang, Xiao Yan ^a   Li, Yu Cheng ^a  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Berberine; Brain derived neurotrophic factor; Corticosterone; Depression

Indexed keywords

BERBERINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; FLUOXETINE; MESSENGER RNA; ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPAL TISSUE; HIPPOCAMPUS; IMMOBILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUCROSE PREFERENCE TEST; SUGAR INTAKE; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOTOR ACTIVITY; PSYCHOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BERBERINE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEPRESSION; HIPPOCAMPUS; MALE; MICE, INBRED ICR; MOTOR ACTIVITY; RNA, MESSENGER; UP-REGULATION;

EID: 84954338705     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.01.002     Document Type: Article

References (39)

1. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 2004, 29:185-193.
2. Fernández-Guasti A., Fiedler J.L., Herrera L., Handa R.J. Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones. Horm. Metab. Res. 2012, 44:607-618.
3. Chen C.L., Willis B.A., Mooney L., Ong G.K., Lim C.N., Lowe S.L., Tauscher-Wisniewski S., Cutler G.B., Wiss S.D. Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation. Br. J. Clin. Pharmacol. 2010, 70:886-894.
4. Gould E., Cameron H.A., Daniels D.C., Woolley C.S., McEwen B.S. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 1992, 12:3642-3650.
5. Anacker C., Cattaneo A., Luoni A., Musaelyan K., Zunszain P.A., Milanesi E., Rybka J., Berry A., Cirulli F., Thuret S., Price J., Riva M.A., Gennarelli M., Pariante C.M. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 2013, 38:872-883.
6. Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., Price J., Pariante C.M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry 2011, 16:738-750.
7. Dinan T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br. J. Psychiatry 1994, 164:365-371.
8. Hinkelmann K., Moritz S., Botzenhardt J., Muhtz C., Wiedemann K., Kellner M., Otte C. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology 2012, 37:685-692.
9. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L. A mouse model of depression induced by repeated corticosterone injections. Eur. J. Pharmacol. 2008, 581:113-120.
10. Yi L.T., Li J., Li H.C., Zhou Y., Su B.F., Yang K.F., Jiang M., Zhang Y.T. Ethanol extracts from Hemerocallis citrina attenuate the decreases of brain-derived neurotrophic factor, TrkB levels in rat induced by corticosterone administration. J. Ethnopharmacol. 2012, 144:328-334.
11. Rosa P.B., Ribeiro C.M., Bettio L.E., Colla A., Lieberknecht V., Moretti M., Rodrigues A.L. Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice. Pharmacol. Biochem. Behav. 2014, 127:1-6.
12. Ali S.H., Madhana R.M., Athira K.V., Kasala E.R., Bodduluru L.N., Pitta S., Mahareddy J.R., Lahkar M. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice. Steroids 2015, 101:37-42.
13. Lee B., Sur B., Shim I., Lee H., Hahm D.H. Angelica gigas ameliorate depression-like symptoms in rats following chronic corticosterone injection. BMC Complement. Altern. Med. 2015, 15:210.
14. Ortiz L.M., Lombardi P., Tillhon M., Scovassi A.I. Berberine, an epiphany against cancer. Molecules 2014, 19:12349-12367.
15. Li Z., Geng Y.N., Jiang J.D., Kong W.J. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid. Based Complement. Altern. Med. 2014, 2014. 289264.
16. Zhang J., Yang J.Q., He B.C., Zhou Q.X., Yu H.R., Tang Y., Liu B.Z. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease. Saudi Med. J. 2009, 30:760-766.
17. Peng W.H., Lo K.L., Lee Y.H., Hung T.H., Lin Y.C. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci. 2007, 81:933-938.
18. Lee B., Sur B., Yeom M., Shim I., Lee H., Hahm D.H. Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats. Korean J. Physiol. Pharmacol. 2012, 16:379-386.
19. Kulkarni S.K., Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur. J. Pharmacol. 2008, 589:163-172.
20. Wu T.C., Chen H.T., Chang H.Y., Yang C.Y., Hsiao M.C., Cheng M.L., Chen J.C. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 2013, 38:871-883.
21. Mao Q.Q., IP S.P., Ko K.M., Tsai S.H., Che C.T. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1211-1216.
22. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
23. Freitas A.E., Egea J., Buendia I., Gómez-Rangel V., Parada E., Navarro E., Casas A.I., Wojnicz A., Ortiz J.A., Cuadrado A., Ruiz-Nuño A., Rodrigues A.L., Lopez M.G. Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol. Neurobiol. 2005, [Epub ahead of print]. 10.1007/s12035-015-9182-6.
24. Johnson S.A., Fournier N.M., Kalynchuk L.E. Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav. Brain Res. 2006, 168:280-288.
25. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
26. Huang Z., Zhong X.M., Li Z.Y., Feng C.R., Pan A.J., Mao Q.Q. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neurosci. Lett. 2011, 493:145-148.
27. Lee B., Shim I., Lee H.J., Yang Y., Hahm D.H. Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci. Lett. 2009, 453:151-156.
28. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H. BDNF function and intracellular signaling in neurons. Histol. Histopathol. 2010, 25:237-258.
29. Adachi M., Barrot M., Autry A.E., Theobald D., Monteggia L.M. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 2008, 63:642-649.
30. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., Ruberto A., Tatarelli R., Nicoletti F., Girardi P., Shelton R.C. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J. Psychiatr. Res. 2009, 43:247-254.
31. Fernandes B.S., Gama C.S., Ceresér K.M., Yatham L.N., Fries G.R., Colpo G., de Lucena D., Kunz M., Gomes F.A., Kapczinski F. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J. Psychiatr. Res. 2011, 45:995-1004.
32. Li S., Wang C., Wang M., Li W., Matsumoto K., Tang Y. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sci. 2007, 80:1373-1381.
33. Yi L.T., Li J., Liu B.B., Luo L., Liu Q., Geng D. BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. J. Psychiatry Neurosci. 2014, 39:348-359.
34. Yi L.T., Li J., Liu Q., Geng D., Zhou Y.F., Ke X.Q., Chen H., Weng L.J. Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. J. Psychopharmacol. 2013, 27:459-468.
35. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?. Psychoneuroendocrinology 2011, 36:415-425.
36. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H. BDNF function and intracellular signaling in neurons. Histol. Histopathol. 2010, 25:237-258.
37. Gourley S.L., Wu F.J., Kiraly D.D., Ploski J.E., Kedves A.T., Duman R.S., Taylor J.R. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 2008, 63:353-359.
38. Anacker C., Cattaneo A., Musaelyan K., Zunszain P.A., Horowitz M., Molteni R., Luoni A., Calabrese F., Tansey K., Gennarelli M., Thuret S., Price J., Uher R., Riva M.A., Pariante C.M. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8708-8713.
39. Zhang X.L., Zhang X.J., Wang C.H., Li Y.H., Dong L.P., Cui L.L., Wang L.N., Liu Z.J., Qiao H.M., Zhu C.H., Xing Y.X., Cao X.Y., Ji Y., Zhao K. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability. Brain Res. 2012, 1459:61-70.